Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SWITZERLAND'S AC IMMUNE OPENS FOR TRADING ON NASDAQ LAUSANNE, Switzerland, Sept. 23, 2016 (GLOBE NEWSWIRE) -- AC Immune SA, a Swiss-based, clinical stage biopharmaceutical company focused on...
-
SWITZERLAND'S AC IMMUNE OPENS FOR TRADING ON NASDAQ Lausanne, Switzerland, September 23, 2016 - AC Immune SA, a Swiss-based, clinical stage biopharmaceutical company focused on neurodegenerative...
-
AC Immune Announces Pricing of Upsized Initial Public Offering Lausanne, Switzerland - September 23, 2016 - AC Immune SA announced today the pricing of its initial public offering of 6,000,000 of...
-
LAUSANNE, Switzerland, Sept. 13, 2016 (GLOBE NEWSWIRE) -- AC Immune SA announced today that it has commenced the initial public offering of 4,545,456 of its common shares pursuant to a registration...
-
AC Immune Commences Proposed Initial Public Offering of Common Shares Lausanne, Switzerland - September 13, 2016 - AC Immune SA announced today that it has commenced the initial public...